Research has indicated that COVID‐19 exacerbates fibrosis in individuals with pulmonary fibrosis,95 and elevated levels of CTGF and TGF‐β have been observed in AECs infected with SARS‐CoV‐2.96 Here, TGFB1 is linked to pulmonary fibrosis.